Nurse Practitioner, Gerontology · Birmingham, AL
NPI
1548292345
Since 2006
Specialty
Nurse Practitioner, Gerontology
Code 363LG0600X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1717 6th Ave S
Birmingham, AL, 35233
Phone (800) 822-8816
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
329 services
Medicare patients, 2024
134
Average age 74
Drug cost, 2024
$140K
853 prescriptions
Company payments, 2025
$123
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rhonda McCormick was code 99214 (office e&m - established), 80 times for 55 patients. In total Rhonda McCormick billed 329 services in 15 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 80 | 55 | $56.67 | $4,534 |
| 99213 Office E&M - Established | Facility | 68 | 54 | $37.71 | $2,564 |
| 91120 Test - Miscellaneous | Facility | 34 | 34 | $25.00 | $850 |
| 91122 Test - Miscellaneous | Facility | 34 | 34 | $46.20 | $1,571 |
| 99212 Office E&M - Established | Facility | 17 | 17 | $19.24 | $327 |
By year: 2022 $17K for 362 services; 2023 $19K for 457 services; 2024 $13K for 329 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rhonda McCormick prescribed most often to Medicare patients was Estradiol, with 113 prescriptions and refills. In total Rhonda McCormick wrote 853 Medicare prescriptions that cost $140K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 113 | 316 | 72 | $9,532 |
| Myrbetriq Mirabegron | 90 | 110 | 25 | $49K |
| Fesoterodine Fumarate Er Fesoterodine Fumarate | 77 | 115 | 22 | $14K |
| Trospium Chloride Generic | 69 | 131 | 30 | $3,181 |
| Loperamide Loperamide Hcl | 61 | 70 | 20 | $1,377 |
| Trospium Chloride Er Trospium Chloride | 44 | 84 | 16 | $11K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 31 | 63 | 12 | $965 |
| Gemtesa Vibegron | 27 | 40 | 11 | $19K |
| Solifenacin Succinate Generic | 25 | 47 | 11 | $1,307 |
| Darifenacin Er Darifenacin Hydrobromide | 24 | 30 | Under 11 | $3,197 |
| Fluconazole Generic | 21 | 21 | Under 11 | $155 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 18 | 18 | 15 | $172 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 17 | 27 | Under 11 | $2,543 |
| Colestipol Hcl Generic | 16 | 32 | Under 11 | $1,373 |
| Cyclobenzaprine Hcl Generic | 16 | 22 | Under 11 | $56.9 |
Brand drugs: 161 claims; generic drugs: 692 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rhonda McCormick $123 ($123 in general payments such as food, travel and fees) from 2 companies. The largest payer was Otsuka Pharmaceutical Development & Commercialization, Inc. with $97.73.
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $97.73 |
| Kerecis Limited | 1 | $24.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.